comparemela.com

Latest Breaking News On - Plasma cell myeloma - Page 1 : comparemela.com

Do No Harm: What Smoldering Myeloma Teaches Us

Manni Mohyuddin, MD, highlights how he treats smoldering multiple myeloma.

Roberta kyleMultiple myelomaPlasma cell myelomaAlignant neoplasiaAlignant neoplasmSmoldering multiple myelomaMoldering multiple myeloma smmX rayBone densityBone mineral densityBone marrowEdulla osseaCancer riskKidney cancerAdrenal cancerBiologic therapy

Abecma Approved for Earlier Lines in R/R Multiple Myeloma

The drug manufacturers report a complete response rate of 39% with idecabtagene vicleucel (Abecma) vs 5% with standard regimens.

Bristol myers squibbDrug administrationMultiple myelomaPlasma cell myelomaChimeric antigen receptort cell therapyChimeric antigen receptorsHimeric immunoreceptorsHimerict cell receptorsRtificialt cell receptorsArt chimaeric antigen receptort cell therapy receptors immunoreceptors chimaerictBiologic therapy

Multiple Myeloma: What Treatments Work Best?

The longest overall survival of nearly 8-10 years was with autologous stem cell transplantation.

Niels abildgaardOdense university hospitalTakeda pharmaceuticals internationalEuropean journalMultiple myelomaPlasma cell myelomaTransplantation of stem cellsRansplantation of hematopoietic stem cellsHematopoietic stem cell transplantStem cell transplantationStem cell therapyTem cell haematopoietic stem transplantSct hematopoietic stem cell transplantation hsct haematopoietic

Belantamab Mafodotin Tops Daratumumab in Multiple Myeloma

The phase 3 study findings supported belantamab mafodotin as a potential new standard of care in the second line or later among patients with released/refractory multiple myeloma.

Castillay leópMaria victoria mateosUniversity hospital of salamancaUniversity hospitalMultiple myelomaPlasma cell myelomaProteasome inhibitorBiologic therapyAnemia anaemiaMonoclonal antibody

Young Myeloma Specialist Forges Ahead, Gives Back

"Manni" Mohyuddin, MD, reflects on patient needs, compassionate care, medical education, and recent advances in treating multiple myeloma.

United statesSan diegoSalt lake cityUniversity of utahGhulam rehman manni mohyuddinUniversity of kansasAga khan universityAmerican society of hematologyAmerican societyGhulam rehmanCommon sense oncologySouth asianMultiple myelomaPlasma cell myelomaMedical lifeHysician lifestyle

vimarsana © 2020. All Rights Reserved.